← Back to Search

Imaging

Imaging of Tumor or Lymph node for Solid Tumors (OU-SCC-MSOT Trial)

N/A

Waitlist Available

Led By Lacey McNally, PhD

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

OU-SCC-MSOT Trial Summary

This trial will help researchers learn if a new imaging tool is safe and can detect tumors and lymph nodes.

OU-SCC-MSOT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evaluate Skin Temperature Pre and Post Imaging (Pre- and Post- Surgery)

Number of Participants With Adverse Events Due to MSOT Imaging

Secondary outcome measures

Tumor Positivity Based on Detection of Deoxy-hemoglobin Using MSOT

Tumor Positivity Based on Detection of Oxy-hemoglobin Using MSOT Device.

Tumor Positivity From Pathology Reports Compared to MSOT Readings

OU-SCC-MSOT Trial Design

1Treatment groups

Experimental Treatment

Group I: Imaging of Tumor or Lymph nodeExperimental Treatment2 Interventions

Tumors and/or lymph nodes of patients scheduled for standard of care surgery will be imaged using the MSOT device before and after surgery. The temperature of their skin prior to and after MSOT imaging will also be measured.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MSOT Device

2020

N/A

~60

Temperature Measurement

2020

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

95,869 Total Patients Enrolled

Lacey McNally, PhDPrincipal InvestigatorUniversity of Oklahoma

1 Previous Clinical Trials

100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for enrolment in this research endeavor at present?

"According to clinicaltrials.gov, this experiment is not presently requesting participants; it was initially posted on July 22nd 2020 and last updated October 5th 2022. However, there are 449 other studies currently recruiting individuals for participation."

Answered by AI

What are the key aims of this scientific experiment?

"The primary outcome for this trial, observed over a 1-2 minute interval of time, is to Monitor Skin Temperature Before and After Imaging (Pre- and Post- Surgery). Secondary endpoints consist of Tumor Positivity Found via MSOT Detection which entails the MSOT device being able to identify cancerous cells on account of their distinct oxygenation states in comparison with healthy tissue. This will be ascertained by gauging deoxygenated hemoglobin levels from an identical ROI region across both tumor and noncancerous samples from the same patient. Greater intensity signals are indicative of higher amounts of deoxyhemoglobin that confirms a"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors

2020. "A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04365413.